Skip to menu Skip to content Skip to footer

2001

Journal Article

New perspectives on the role of aldosterone excess in cardiovascular disease

Stowasser, M (2001). New perspectives on the role of aldosterone excess in cardiovascular disease. Clinical And Experimental Pharmacology And Physiology, 28 (10), 783-791. doi: 10.1046/j.1440-1681.2001.03523.x

New perspectives on the role of aldosterone excess in cardiovascular disease

2001

Journal Article

Primary aldosteronism: Rare bird or common cause of secondary hypertension?

Stowasser, M. (2001). Primary aldosteronism: Rare bird or common cause of secondary hypertension?. Current Hypertension Reports, 3 (3), 230-239.

Primary aldosteronism: Rare bird or common cause of secondary hypertension?

2000

Journal Article

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

Collins, D., Coombes, J., Staatz, C. E., Stowasser, D. and Stowasser, M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-52.

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

2000

Journal Article

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

Bofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, Richard D. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94.

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

2000

Journal Article

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

Bofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, R. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. doi: 10.1038/sj.jhh.1000935

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

2000

Journal Article

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

Stowasser, Danielle A., Staatz, Christine E., Stowasser, Michael, Coombes, Judith A. and Collins, David M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-53. doi: 10.1002/jppr200030247

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

2000

Journal Article

Primary aldosteronism: learning from the study of familial varieties

Stowasser, M and Gordon, RD (2000). Primary aldosteronism: learning from the study of familial varieties. Journal of Hypertension, 18 (9), 1165-1176. doi: 10.1097/00004872-200018090-00002

Primary aldosteronism: learning from the study of familial varieties

2000

Journal Article

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)

Lafferty, Antony R., Torpy, David J., Stowasser, Michael, Taymans, Susan E., Lin, Jing Ping, Huggard, Philip, Gordon, Richard D. and Stratakis, Constantine A. (2000). A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). Journal of Medical Genetics, 37 (11), 831-835. doi: 10.1136/jmg.37.11.831

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)

2000

Journal Article

Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance

Stowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance. The Journal of Clinical Endocrinology and Metabolism, 85 (6), 2160-2166. doi: 10.1210/jc.85.6.2160

Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance

2000

Journal Article

Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension

Stowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension. Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jcem.85.9.6834

Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension

2000

Journal Article

Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p

Benn, DE, Dwight, T, Richardson, AL, Delbridge, L, Bambach, CP, Stowasser, M, Gordon, RD, Marsh, DJ and Robinson, BG (2000). Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Research, 60 (24), 7048-7051.

Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p

2000

Journal Article

How common is adrenal-based mineralocortoid hypertension?

Stowasser, M. (2000). How common is adrenal-based mineralocortoid hypertension?. Current Opinion in Endocrinology & Diabetes, 7 (3), 143-150. doi: 10.1097/00060793-200006000-00007

How common is adrenal-based mineralocortoid hypertension?

2000

Journal Article

Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension

Stowasser, M, Bachmann, AW and Gordon, RD (2000). Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. The Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jc.85.9.3313

Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension

1999

Journal Article

Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers

Bofinger, A. M., Hawley, C. M., Fisher, P. M., Daunt, N., Stowasser, M. and Gordon, Richard D. (1999). Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. Journal of Human Hypertension, 13 (8), 517-520.

Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers

1999

Journal Article

Expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma

Coulter, Catherine L., Smith, Robin E., Stowasser, Michael, Sasano, Hironobu, Krozowski, Zygmunt S. and Gordon, Richard D. (1999). Expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma. Mollecular and Cellular endocrinology, 154 (1-2), 71-77. doi: 10.1016/S0303-7207(99)00077-5

Expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma

1999

Journal Article

Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers

Bofinger, AM, Hawley, CM, Fisher, PM, Daunt, N, Stowasser, M and Gordon, RD (1999). Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. Journal of Human Hypertension, 13 (8), 517-520. doi: 10.1038/sj.jhh.1000873

Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers

1999

Journal Article

Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I

Stowasser, M, Huggard, PR, Rossetti, TR, Bachmann, AW and Gordon, RD (1999). Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. Journal of Clinical Endocrinology and Metabolism, 84 (11), 4031-4036. doi: 10.1210/jc.84.11.4031

Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I

1998

Journal Article

Expression of 11 beta HSD-2 in human adrenal cortical carcinoma and adenoma

Coulter, CL, Smith, RE, Stowasser, M, Sasano, H, Krozowski, ZS and Gordon, RD (1998). Expression of 11 beta HSD-2 in human adrenal cortical carcinoma and adenoma. Endocrine Research, 24 (3-4), 875-876.

Expression of 11 beta HSD-2 in human adrenal cortical carcinoma and adenoma

1998

Journal Article

Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene

Torpy, DJ, Gordon, RD, Lin, JP, Huggard, PR, Taymans, SE, Stowasser, M, Chrousos, GP and Stratakis, CA (1998). Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. Journal of Clinical Endocrinology And Metabolism, 83 (9), 3214-3218. doi: 10.1210/jc.83.9.3214

Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene

1998

Journal Article

Familial forms broaden the horizons for primary aldosteronism

Gordon, RD and Stowasser, M (1998). Familial forms broaden the horizons for primary aldosteronism. Trends In Endocrinology And Metabolism, 9 (6), 220-227. doi: 10.1016/S1043-2760(98)00058-7

Familial forms broaden the horizons for primary aldosteronism